SAFE vs CCPS in Indian early-stage rounds: which one actually fits

Roughly one in three early-stage founders we sit down with opens with the same line. They want to do a SAFE. They've read about Y Combinator's instrument, talked to a peer who closed one in Delaware, and they like the idea of a five-page document and a ten-day close. They are about to be told by their lawyer that what they are signing is actually a CCPS. The translation happens quickly, often without much explanation, and the founder ends up with an instrument that looks similar on the cover page and behaves quite differently underneath.

Worth understanding why.

Why SAFEs don't really fit India

A SAFE — Simple Agreement for Future Equity — is, in its US form, neither debt nor equity. It is a contractual right to receive shares at the next priced round. No interest accrues. No maturity date. The investor wires money today, the company issues preferred shares later, and in the meantime the SAFE sits on the cap-table as a contingent claim.

Indian law does not have a clean shelf for this kind of instrument. Two frictions surface immediately.

FEMA pricing guidelines. If the SAFE investor is non-resident — which most early SAFE investors are — RBI's pricing rules under the FEMA Non-Debt Instruments Rules apply. Foreign capital coming into an Indian company has to convert into a permitted instrument at a price that is at or above the fair value determined under prescribed methods. A SAFE that promises shares at an undefined future price doesn't satisfy this. The instrument has to either be denominated as a convertible from day one, with a defined conversion mechanic, or it sits in a legal grey zone that no Big Four advisor will sign off on.

Companies Act, 2013 — Section 42 and 62. Private placements of securities in India require a defined instrument, a board resolution authorising the issue, a return of allotment filed with the ROC within 15 days, and pricing that ties back to a valuation report from a registered valuer. A SAFE that doesn't allot shares at signing fails this on multiple counts. To make it work, Indian counsel typically restructures the instrument as a Compulsorily Convertible Preference Share — CCPS — issued at a defined price with a defined conversion ratio that adjusts at the next round.

The economic intent of the SAFE survives. The legal form changes. The founder signs what looks like a SAFE on the term sheet and a CCPS subscription agreement at closing. Most don't notice the difference until something goes wrong.

What a CCPS actually is

A CCPS is a preference share that must convert into equity by a defined trigger — either a next round, an IPO, or a longest-stop date typically set at 19 or 20 years from issuance. Three mechanics matter.

Conversion ratio. The CCPS converts into a defined number of equity shares. The ratio is set at the next priced round, usually with a valuation cap and a discount that mirror SAFE economics. If the cap is ₹100 crore and the discount is 20%, the conversion price is the lower of (a) the next-round price per share applied to a ₹100 crore pre-money, or (b) the next-round price discounted by 20%. The CCPS holder ends up with whichever count of equity shares this calculation produces.

Dividend optionality. Indian CCPS instruments must specify a dividend rate — even if nominal. Most early-stage CCPS carry a 0.0001% coupon that is functionally a placeholder. The Companies Act requires the rate be defined; founders sometimes wave it through without realising they've technically agreed to a preferential dividend that, in a year of profitability, the company is obligated to declare before any equity dividend.

Anti-dilution. Most CCPS subscription agreements carry a broad-based weighted-average anti-dilution clause. SAFEs in the US version usually don't — the YC post-money SAFE adjusts only via the valuation cap. When Indian counsel converts the SAFE to a CCPS, the anti-dilution clause is often inserted as standard boilerplate. Founders rarely push back. They should.

The valuation-cap trap

The single biggest pattern we see is founders signing a CCPS with a valuation cap they treat as a SAFE-style cap and discovering at the next round that the math is meaningfully different.

Here's a concrete example. Founder raises ₹4 crore on a CCPS with a ₹40 crore valuation cap and a 20% discount. Twelve months later, Series A closes at a ₹120 crore pre-money valuation. The founder expects the CCPS holder to convert at the ₹40 crore cap — implying the holder owns roughly 10% post-conversion.

What actually happens depends on how the CCPS subscription agreement defines the conversion mechanic. If it's a pre-money cap (US-style YC SAFE before the 2018 redraft), the holder converts at the cap price, but the share count is calculated against the pre-money cap-table. The dilution from the Series A then falls partly on the CCPS holder too. They end up with closer to 8% post-Series A.

If it's a post-money cap (post-2018 YC SAFE), the holder is protected from Series A dilution. They convert into a defined percentage of the post-money cap-table — closer to 10% — and the founders absorb the dilution.

Indian CCPS subscription agreements are written by lawyers who default to whatever boilerplate sits in their templates. Some are pre-money. Some are post-money. Some are ambiguous in a way that gets litigated at the Series A. The founder signed without checking. The CCPS holder's lawyer reads the document at conversion and asserts the interpretation that benefits their client.

The valuation cap is not just a ceiling. It is a definition of which side of the cap-table absorbs the next round's dilution. Read it like that.

When a SAFE still works

There are narrow scenarios where a true SAFE is the right instrument.

Foreign holding company structures. If the company has a Delaware or Singapore parent that owns the Indian operating subsidiary, the SAFE can be issued at the parent level under that jurisdiction's law. The Indian operating company is unaffected. This is the standard structure for Indian founders building global products who set up a Delaware C-corp on day one. The SAFE is genuinely a SAFE, governed by Delaware law, with Y Combinator's standard form.

Mauritius or Singapore investor routing. A non-resident investor coming through a Mauritius or Singapore vehicle, investing into an Indian company, still hits FEMA pricing rules. The SAFE doesn't help here. The conversion to CCPS is unavoidable. We see founders assume the offshore routing changes the answer; it doesn't.

Internal bridge from existing shareholders. Existing Indian shareholders putting in a small bridge that will convert at the next round can sometimes use a convertible note structure — issued under Section 62(3) — that approximates SAFE economics without the foreign-investor friction. This is the closest Indian-law-native analogue to a SAFE for resident capital.

A cleaner mental model

Stop thinking about SAFE versus CCPS. Think about three questions, in order.

First — where does the money come from. Resident Indian capital, non-resident capital, or a mix. The answer narrows the instrument set immediately.

Second — what's the conversion mechanic. Pre-money cap, post-money cap, or a fixed conversion price. Each has different cap-table consequences at the next round.

Third — what protections does the investor get between signing and conversion. Anti-dilution, information rights, transfer restrictions, pro-rata. These get drafted into the CCPS subscription agreement and most founders never read them.

A worked cap-table example

Walk this through with the numbers visible. Pre-CCPS cap-table: founders 100%. Company raises ₹4 crore on a CCPS with a ₹40 crore valuation cap and a 20% discount. The CCPS sits on the cap-table as a contingent instrument; no equity dilution happens at signing, though the instrument is recorded under preference share capital.

Twelve months later, Series A closes. Headline: ₹30 crore raised at ₹120 crore pre-money, ₹150 crore post-money. New investor takes 20% of the post-money cap-table.

CCPS conversion mechanic kicks in. Two possible prices: (a) cap-implied price, calculated as ₹40 crore divided by the fully-diluted share count at conversion; (b) discounted next-round price, calculated as the Series A price per share multiplied by 0.80. Whichever is lower binds.

In a healthy up round, the cap-implied price is almost always lower. The CCPS holder converts at the cap, taking a share count equivalent to roughly 10% of the pre-Series A cap-table (₹4 crore at ₹40 crore implied valuation = 10%). The Series A then dilutes everyone, including the converted CCPS holder, by the new 20% taken by the lead.

Post-Series A cap-table: founders roughly 72%, CCPS holder roughly 8%, Series A lead 20%. The CCPS holder's effective ownership after the Series A dilution is lower than the 10% the cap implied — because the cap was pre-money relative to Series A.

If the same CCPS had been written with a post-money cap mechanic — the holder converts into a fixed 10% of the post-Series A cap-table — the founder dilution would have been higher. Founders roughly 70%, CCPS 10%, Series A 20%. The 2 percentage-point swing on the founder slice is exactly the dilution the CCPS holder is protected from under the post-money structure.

Neither is right or wrong. Both are defensible. The point is to choose deliberately, document the choice, and model the cap-table under both interpretations before signing.

What we run with founders at engagement

Two-hour working session. Pull the draft term sheet, the SAFE template the founder thinks they're signing, and the subscription agreement Indian counsel is drafting. Walk through each clause and compare. Identify where the economic intent diverges. Where it does, redraft the subscription agreement before signing — not after.

Most founders save 1–3 percentage points of ownership at the next round through this exercise. Nobody who has done it has called it wasted time.